Astrazeneca (AZN) Selling, General & Administrative (2009 - 2026)
Astrazeneca (AZN) reported Selling, General & Administrative of -$5.65 billion for Q2 2026, compared with -$4.86 billion a year earlier.
Powered by 
Analysis
Astrazeneca (AZN) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Astrazeneca's Selling, General & Administrative came in at -$15.45 billion; for FY2025, it came in at -$19.93 billion.
- By year, Selling, General & Administrative came in at -$19.98 billion in FY2024, -$19.22 billion in FY2023, -$18.42 billion in FY2022 and -$15.23 billion in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Selling, General & Administrative since Q4 2014.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$4.92 billion (Q1 2026), $205 million (Q4 2025) and -$5.09 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 582.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.65 Bn |
| Mar 31, 2026 | -4.92 Bn |
| Dec 31, 2025 | 205.00 Mn |
| Sep 30, 2025 | -5.09 Bn |
| Jun 30, 2025 | -4.86 Bn |
| Mar 31, 2025 | -4.49 Bn |
| Dec 31, 2024 | -5.41 Bn |
| Sep 30, 2024 | -5.14 Bn |
| Jun 30, 2024 | -4.93 Bn |
| Mar 31, 2024 | -4.50 Bn |
| Dec 31, 2023 | -5.37 Bn |
| Sep 30, 2023 | -4.80 Bn |
| Jun 30, 2023 | -4.99 Bn |
| Mar 31, 2023 | -4.06 Bn |
| Dec 31, 2022 | -4.62 Bn |
| Sep 30, 2022 | -4.28 Bn |
| Jun 30, 2022 | -4.68 Bn |
| Mar 31, 2022 | -4.84 Bn |
| Dec 31, 2021 | -5.12 Bn |
| Sep 30, 2021 | -4.09 Bn |
API Access
Astrazeneca Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();